Mitotic checkpoint slippage in humans occurs via cyclin B destruction in the presence of an active checkpoint

被引:424
作者
Brito, Daniela A.
Rieder, Conly L. [1 ]
机构
[1] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12222 USA
[2] New York State Dept Hlth, Wadsworth Ctr, Div Mol Med, Lab Cell Regulat, Albany, NY 12201 USA
关键词
D O I
10.1016/j.cub.2006.04.043
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In the presence of unattached/weakly attached kineto-chores, the spindle assembly checkpoint (SAC) delays exit from mitosis by preventing the anaphase-promoting complex (APC)-mediated proteolysis of cyclin B, a regulatory subunit of cyclin-dependent kinase 1 (Cdk1). Like all checkpoints, the SAC does not arrest cells permanently, and escape from mitosis in the presence of an unsatisfied SAC requires that cyclin B/Cdk1 activity be inhibited. In yeast [1-5], and likely Drosophila [6-8], this occurs through an "adaptation" process involving an inhibitory phosphorylation on Cdk1 and/or activation of a cyclin-dependent kinase inhibitor (Cdki). The mechanism that allows vertebrate cells to escape mitosis when the SAC cannot be satisfied is unknown. To explore this issue, we conducted fluorescence microscopy studies on rat kangaroo (PtK) and human (RPE1) cells dividing in the presence of nocodazole. We find that in the absence of microtubules (MTs), escape from mitosis occurs in the presence of an active SAC and requires cyclin B destruction. We also find that cyclin B is progressively destroyed during the block by a proteasome-dependent mechanism. Thus, vertebrate cells do not adapt to the SAC. Rather, our data suggest that in normal cells, the SAC cannot prevent a slow but continuous degradation of cyclin B that ultimately drives the cell out of mitosis.
引用
收藏
页码:1194 / 1200
页数:7
相关论文
共 31 条
  • [1] MICROTUBULE DEPENDENCY OF P34(CDC2) INACTIVATION AND MITOTIC EXIT IN MAMMALIAN-CELLS
    ANDREASSEN, PR
    MARGOLIS, RL
    [J]. JOURNAL OF CELL BIOLOGY, 1994, 127 (03) : 789 - 802
  • [2] Caspases-dependent cleavage of mitotic checkpoint proteins in response to microtubule inhibitor
    Baek, KH
    Shin, HJ
    Jeong, SJ
    Park, JW
    McKeon, F
    Lee, CW
    Kim, CM
    [J]. ONCOLOGY RESEARCH, 2005, 15 (03) : 161 - 168
  • [3] Mutations of mitotic checkpoint genes in human cancers
    Cahill, DP
    Lengauer, C
    Yu, J
    Riggins, GJ
    Willson, JKV
    Markowitz, SD
    Kinzler, KW
    Vogelstein, B
    [J]. NATURE, 1998, 392 (6673) : 300 - 303
  • [4] Degradation of cyclin B is required for the onset of anaphase in mammalian cells
    Chang, DC
    Xu, NH
    Luo, KQ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (39) : 37865 - 37873
  • [5] Chen JG, 2002, CANCER RES, V62, P1935
  • [6] Temporal and spatial control of cyclin B1 destruction in metaphase
    Clute, P
    Pines, J
    [J]. NATURE CELL BIOLOGY, 1999, 1 (02) : 82 - 87
  • [7] Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency
    Dai, W
    Wang, Q
    Liu, TY
    Swamy, M
    Fang, YQ
    Xie, SQ
    Mahmood, R
    Yang, YM
    Xu, M
    Ra, CV
    [J]. CANCER RESEARCH, 2004, 64 (02) : 440 - 445
  • [8] Rux is a cyclin-dependent kinase inhibitory (CKI) specific for mitotic cyclin-Cdk complexes
    Foley, E
    O'Farrell, PH
    Sprenger, F
    [J]. CURRENT BIOLOGY, 1999, 9 (23) : 1392 - 1402
  • [9] The cyclin-dependent kinase inhibitor Roughex is involved in mitotic exit in Drosophila
    Foley, E
    Sprenger, F
    [J]. CURRENT BIOLOGY, 2001, 11 (03) : 151 - 160
  • [10] Changes in the tear proteins of diabetic patients
    Grus F.H.
    Sabuncuo P.
    Dick H.B.
    Augustin A.J.
    Pfeiffer N.
    [J]. BMC Ophthalmology, 2 (1) : 1 - 6